Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 IRB Approval for Anatabloc Human Clinical Study - Nutraceuticals World

What are you searching for?

Sign in
Regulations

IRB Approval for Anatabloc Human Clinical Study

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Star Scientific, Inc., Glen Allen, VA, through its subsidiary, Rock Creek Pharmaceuticals, Inc., Gloucester, MA, has announced that it has received IRB approval of the first human clinical study of the safety and effects of nutritional supplementation with Anatabloc in individuals with Alzheimer’s disease. The study is a six-visit, double-blind, randomized, placebo-controlled, parallel-group trial to evaluate the safety, tolerability and potential effects of Anatabine dietary supplementation in subjects with mild to moderate Alzheimer’s disease. Secondary aims are to evaluate the effects of this specially formulated version of Anatabloc (patent pending) on amyloid beta, global outcome and functional measures of Alzheimer’s. 

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics